Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Chadha

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Therapeutics|January 1, 1986
Serum potassium and body weight during treatment with two fixed combinations of beta-blockers and diuretics in hypertensive patients: a controlled studyJ J Houtzagers, C A Sumajow, D R Chadha
The American Journal of Cardiology|June 1, 1996
Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failureJ Lubsen, D R Chadha, Y T Yotof, et al.
European Heart Journal|September 1, 1983
Molsidomine, an effective long-acting anti-anginal drugK Balakumaran, P G Hugenholtz, J G Tijssen, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutololL D Lameijer, L A Voermans, J J Houtzagers, et al.
Clinical Pharmacology and Therapeutics|June 1, 1977
Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low dosesR D Kulkarni, L M DaSilva, N L Chabria, et al.
Lancet (London, England)|November 30, 1985
Long-term effects of buserelin on plasma testosterone and luteinising hormone concentrationsM T Lock, F H de Jong, D R Chadha, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 1986
Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patientsA M Franssen, R Rolland, D R Chadha, et al.
Fertility and Sterility|March 1, 1989
Endometriosis: treatment with gonadotropin-releasing hormone agonist BuserelinA M Franssen, F M Kauer, D R Chadha, et al.
Journal of Clinical Pharmacology|May 1, 1975
Intense surveillance of adverse drug reactions. An analysis of 338 patientsB J Vakil, R D Kulkarni, N L Chabria, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Therapeutics|January 1, 1986
Serum potassium and body weight during treatment with two fixed combinations of beta-blockers and diuretics in hypertensive patients: a controlled studyJ J Houtzagers, C A Sumajow, D R Chadha
The American Journal of Cardiology|June 1, 1996
Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failureJ Lubsen, D R Chadha, Y T Yotof, et al.
European Heart Journal|September 1, 1983
Molsidomine, an effective long-acting anti-anginal drugK Balakumaran, P G Hugenholtz, J G Tijssen, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutololL D Lameijer, L A Voermans, J J Houtzagers, et al.
Clinical Pharmacology and Therapeutics|June 1, 1977
Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low dosesR D Kulkarni, L M DaSilva, N L Chabria, et al.
Lancet (London, England)|November 30, 1985
Long-term effects of buserelin on plasma testosterone and luteinising hormone concentrationsM T Lock, F H de Jong, D R Chadha, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 1986
Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patientsA M Franssen, R Rolland, D R Chadha, et al.
Fertility and Sterility|March 1, 1989
Endometriosis: treatment with gonadotropin-releasing hormone agonist BuserelinA M Franssen, F M Kauer, D R Chadha, et al.
Journal of Clinical Pharmacology|May 1, 1975
Intense surveillance of adverse drug reactions. An analysis of 338 patientsB J Vakil, R D Kulkarni, N L Chabria, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Pageof 2